Table 1. Patient characteristics... | American Society of Hematology

Table 1.

Patient characteristics

Characteristics		All patients
Characteristics		N = 179	%
Race	White non-Hispanic	124	69
	Black or Afro-American	24	13
	Asian	6	3
	Not available	3	2
Ethnicity	Not Hispanic or Latino	157	88
	Hispanic or Latino	22	12
Sex	Female	79	44
	Male	100	56
Subtype of cHL	Nodular sclerosis	110	61
	Lymphocyte rich	2	1
	Mixed cellularity	12	7
	Lymphocyte depleted	1	1
	NOS	47	26
	Nodular sclerosis syncytial variant	3	2
	HIV associated	3	2
	Iatrogenic immunodeficiency, EBV⁺	1	1
Stage	III	49	27
	IV	130	73
ECOG	Not available	3	2
	0	95	53
	1	73	41
	2	7	4
	3	1	1
B symptoms	Absent	61	34
	Present	118	66
IPS	0 or 1	18	10
	2 or 3	83	46
	4 to 7	78	44
Age, y	Median (range)	37 (18-79)
	<60	142	79
	≥60	37	21

Characteristics		All patients
Characteristics		N = 179	%
Race	White non-Hispanic	124	69
	Black or Afro-American	24	13
	Asian	6	3
	Not available	3	2
Ethnicity	Not Hispanic or Latino	157	88
	Hispanic or Latino	22	12
Sex	Female	79	44
	Male	100	56
Subtype of cHL	Nodular sclerosis	110	61
	Lymphocyte rich	2	1
	Mixed cellularity	12	7
	Lymphocyte depleted	1	1
	NOS	47	26
	Nodular sclerosis syncytial variant	3	2
	HIV associated	3	2
	Iatrogenic immunodeficiency, EBV⁺	1	1
Stage	III	49	27
	IV	130	73
ECOG	Not available	3	2
	0	95	53
	1	73	41
	2	7	4
	3	1	1
B symptoms	Absent	61	34
	Present	118	66
IPS	0 or 1	18	10
	2 or 3	83	46
	4 to 7	78	44
Age, y	Median (range)	37 (18-79)
	<60	142	79
	≥60	37	21

EBV, Epstein-Barr virus; ECOG, Eastern Cooperative Oncology Group; NOS, not otherwise specified.